Literature DB >> 8598506

Nonspecific effects in longitudinal studies: impact on quality of life measures.

C Bouchet1, F Guillemin, S Briançon.   

Abstract

A variety of factors may influence outcome measures in longitudinal studies, including placebo, Hawthorne, or natural history effects. Quality of life (QoL) measures are particularly subject to these phenomena. This 2-month postal survey was set up to examine the extent of nonspecific effects in a treatment (vitamin supplementation) group (n = 180), a placebo group (n = 180), as part of a stratified, randomized controlled trial, and two control groups (n = 768 each). Quality of life was measured using the SF36. The placebo effect had a significant impact on improving physical, mental, and pain dimensions (p = 0.02 to 0.04), and the Hawthorne effect was significant (p = 0.03 to 0.009) for psychological dimensions. Although the impact of natural history was not significant, it tended to worsen all QoL dimensions. Vitamin supplementation had no effect on QoL. These results demonstrate the importance of placebo and Hawthorne effects and suggest that they may be responsible for misleading results or reductions in the power of controlled trials.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598506     DOI: 10.1016/0895-4356(95)00540-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  18 in total

1.  The Hawthorne effect and energy awareness.

Authors:  Daniel Schwartz; Baruch Fischhoff; Tamar Krishnamurti; Fallaw Sowell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

Review 2.  Placebo effects: clinical aspects and neurobiology.

Authors:  Barry S Oken
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

3.  Randomised active programs on healthcare workers' flu vaccination in geriatric health care settings in France: the VESTA study.

Authors:  M Rothan-Tondeur; Y Filali-Zegzouti; J-L Golmard; B De Wazieres; F Piette; F Carrat; B Lejeune; G Gavazzi
Journal:  J Nutr Health Aging       Date:  2011-02       Impact factor: 4.075

4.  Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation.

Authors:  Abraham G Kocheril; Hugh Calkins; Arjun D Sharma; Daniel Cher; Harrison A Stubbs; Jon E Block
Journal:  J Interv Card Electrophysiol       Date:  2005-04       Impact factor: 1.900

Review 5.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 6.  Placebo Effects in Traumatic Brain Injury.

Authors:  Ginger Polich; Mary Alexis Iaccarino; Ted J Kaptchuk; Leon Morales-Quezada; Ross Zafonte
Journal:  J Neurotrauma       Date:  2018-04-05       Impact factor: 5.269

Review 7.  Can simply answering research questions change behaviour? Systematic review and meta analyses of brief alcohol intervention trials.

Authors:  Jim McCambridge; Kypros Kypri
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

8.  Massage therapy for osteoarthritis of the knee: a randomized dose-finding trial.

Authors:  Adam I Perlman; Ather Ali; Valentine Yanchou Njike; David Hom; Anna Davidi; Susan Gould-Fogerite; Carl Milak; David L Katz
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

9.  The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population.

Authors:  Linda Abetz; Robert Arbuckle; Richard P Allen; Elena Mavraki; Jeffrey Kirsch
Journal:  Health Qual Life Outcomes       Date:  2005-12-05       Impact factor: 3.186

Review 10.  Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate.

Authors:  Gunn Elisabeth Vist; Dianne Bryant; Lyndsay Somerville; Trevor Birminghem; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.